THERAPEUTIC EFFECTS OF SALVADORA PERSICA EXTRACTS AGAINST SARCOPTES SCABIEI VAR. HOMINIS AND THEIR SECONDARY INFECTIONS

Main Article Content

Abbas Shahid
Dr. Amina Arif
Ramisha Ali
Dr. Abdul Aziz
Mian Saeed Sarwar
Mehwish Naeem
Ayesha Nawaz
Syed Rizvan Ali

Keywords

Salvadora Persica, Secondary infections, Scabies, Sarcoptes scabie var. Hominis

Abstract

Salvadora persica, commonly recognized as the Miswak tree, happens in shrub savannah. From northwestern areas. The current evaluation gives a complete summary of the chemical materials and organic results (antibacterial and anti-parasitic specially scabies) of this species. To examine the qualitative and quantitative analyses of methanolic and ethanolic extracts to screen the phytochemical contents, sulfur containing compound present in Salvadora persica against scabies and secondary bacterial infection. Numerous compounds were identified using GCMS analysis, biological activities, Molecular docking and anti-bacterial activity of stem extracts. It contributes to widespread disease brought on by secondary bacterial  infections and post-infectious conditions such acute post-streptococcal glomerulonephritis Sarcoptic scabies mites' variant Hominis can be killed by sulfur-containing compounds. The extract of Salvadora persica have an effect against scabies and the subsequent bacterial infection inside the single dose. They can protect against secondary bacterial scabies infections.  The potential interaction and binding affinity between ligands 2-(2 Methyl vinyl) thiophene, Benzene, (Isothiocyanatomethyl) and Benzyl Nitrile and protein (3h7t) were analyzed by Auto dockvina. The ligand tended to bind with the binding energy -4.3kcal/mol, -5.4kcal/mol and -5.7kcal/mol respectively.

Abstract 184 | PDF Downloads 76

References

[1] A. A. Mohamed, B. M. Alotaibi, Journal of Umm Al-Qura University for Applied Sciences 2023, 9, 40-49.
[2] G. B. Smita, in Natural Medicinal Plants (Ed.: A. E.-S. Hany), IntechOpen, Rijeka, 2021, p. Ch. 12.
[3] M. M. Aye, H. T. Aung, M. M. Sein, C. Armijos, Molecules (Basel, Switzerland) 2019, 24.
[4] F. Şahin, I. Karaman, M. Güllüce, H. Öğütçü, M. Şengül, A. Adıgüzel, S. Öztürk, R. Kotan, Journal of ethnopharmacology 2003, 87, 61-65.
[5] M. Farag, W. M. Abdel-Mageed, A. A. El Gamal, O. A. Basudan, Saudi Pharmaceutical Journal 2021, 29, 751-763.
[6] F. Alali, T. Al-Lafi, Natural product research 2003, 17, 189-194.
[7] aH. R. Poureslami, A. Makarem, F. Mojab, Dental Research Journal 2008, 4, 106-110; bV. Rajesh, P. Suresh, B. Anil, P. Purohit, International Journal of Pharmaceutical & Biological Archives 2010, 6, 9-13.
[8] A. Gupta, S. Verma, P. Kushwaha, S. Srivastava, A. Rawat, Indian J Pharm Educ Res 2015, 49, 71-75.
[9] A. A. o. Pediatrics, Peter G, editor 1997.
[10] A. Hassan, J. Usman, F. Kaleem, M. Omair, A. Khalid, M. Iqbal, Malays J Microbiol 2011, 7, 57-60.
[11] J. E. Stoeken, S. Paraskevas, G. A. Van Der Weijden, Journal of periodontology 2007, 78, 1218-1228.
[12] M. Arora, A. A. Siddiqui, S. Paliwal, Int J Pharm Pharm Sci 2013, 5, 207-210.
[13] D. Stojković, J. Petrović, M. Soković, J. Glamočlija, J. Kukić‐Marković, S. Petrović, Journal of the Science of Food Agriculture 2013, 93, 3205-3208.
[14] M. Khalil, F. Sonbol, Nigerian Journal of Clinical Practice 2014, 17, 776-784.
[15] G. C. Galletti, G. Chiavari, Y. D. Kahie, Rapid communications in mass spectrometry 1993, 7, 651-655.
[16] E. Noumi, M. Snoussi, N. Trabelsi, H. Hajlaoui, R. Ksouri, E. Valentin, A. Bakhrouf, Journal of Medicinal Plants Research 2011, 5, 4138-4146.
[17] A. A. M. Al-Ghamdi, M. El-Zohri, African Journal of Biotechnology 2017, 16, 517-527.
[18] M. Thompson, D. Engelman, K. Gholam, L. Fuller, A. Steer, Journal of Clinical Experimental Dermatology 2017, 42, 481-487.
[19] A. Sofrata, E. M. Santangelo, M. Azeem, A.-K. Borg-Karlson, A. Gustafsson, K. Pütsep, PLoS One 2011, 6, e23045.
[20] A. Mika, S. L. Reynolds, D. Pickering, D. McMillan, K. S. Sriprakash, D. J. Kemp, K. Fischer, PLoS neglected tropical diseases 2012, 6, e1563.
[21] A. Hussain, M. Ali, N. Javed, International Journal of Pharmacy 2011, 2, 103-105.
[22] J. R. Carapetis, A. C. Steer, E. K. Mulholland, M. Weber, The Lancet infectious diseases 2005, 5, 685-694.
[23] M. Farag, W. M. Abdel-Mageed, O. Basudan, A. El-Gamal, Molecules (Basel, Switzerland) 2018, 23, 483.
[24] M. Z. Aumeeruddy, G. Zengin, M. F. Mahomoodally, Journal of ethnopharmacology 2018, 213, 409-444.
[25] M. Khan, H. Z. Alkhathlan, S. T. Khan, Pathogens 2020, 9, 66.
[26] M. Khalil, M. El-Sabbagh, E. El Naggar, R. El-Erian, Nigerian journal of clinical practice 2019, 22, 1378-1387.
[27] M. M. Ghoneim, W. M. Afifi, M. Ibrahim, M. Elagawany, M. T. Khayat, M. H. Aboutaleb, A. M. Metwaly, Pharmacognosy Magazine 2019, 15, 232-237.
[28] S. A. Mohamed, J. A. Khan, BMC complementary and alternative medicine 2013, 13, 1-6.
[29] H. A. El Rabey, F. M. Almutairi, A. I. Al-Sieni, M. N. Al-Seeni, M. A. Al-Duais, M. I. Sakran, M. A. Elbakry, 2017.
[30] T. Hoor, R. Farooqu, J. M. Shaikh, N. Karim, The Professional Medical Journal 2014, 21, 070-074.
[31] M. Petran, D. Dragos, M. Gilca, Journal of ethnobiology and ethnomedicine 2020, 16, 1-33.
[32] M. Afzal, A. S. Khan, B. Zeshan, M. Riaz, U. Ejaz, A. Saleem, R. Zaineb, H. A. Sindhu, C. Y. Yean, N. Ahmed, Molecules (Basel, Switzerland) 2023, 28, 1743.
[33] F. P. Casuga, A. L. Castillo, M. J.-A. T. Corpuz, Asian Pacific Journal of Tropical Biomedicine 2016, 6, 957-961.
[34] A. Nazeer, N. George, Saudi J Med Pharm Sci 2017, 3, 868-872.
[35] R. Perumalsamy, L. Krishnadhas, Applied Biochemistry and Biotechnology 2022, 194, 1136-1148.
[36] M. Bourhia, K. Bouothmany, H. Bakrim, S. Hadrach, A. M. Salamatullah, A. Alzahrani, H. Khalil Alyahya, N. A. Albadr, S. Gmouh, A. Laglaoui, Separations 2021, 8, 114.
[37] A. A. Adedapo, O. O. Falayi, A. A. Oyagbemi, Journal of basic and clinical physiology and pharmacology 2015, 26, 491-499.

Most read articles by the same author(s)